Genetic testing for hereditary prostate cancer: Current status and limitations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genetic testing for hereditary prostate cancer: Current status and limitations

Published:2018-04-18 Issue:15 Volume:124 Page:3105-3117
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Zhen Jun Tu¹²,Syed Jamil²,Nguyen Kevin Anh²,Leapman Michael S.²,Agarwal Neeraj³,Brierley Karina⁴,Llor Xavier⁴,Hofstatter Erin⁴,Shuch Brian²⁴^ORCID

Affiliation:

1. Frank H. Netter School of Medicine at Quinnipiac UniversityNorth Haven Connecticut

2. Department of UrologyYale School of MedicineNew Haven Connecticut

3. Huntsman Cancer CenterUniversity of Utah School of MedicineSalt Lake City Utah

4. Cancer Genetics and Prevention Program, Smilow Cancer Center, Yale School of MedicineNew Haven Connecticut

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.31316

Reference64 articles.

1. Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and Finland

2. Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease

3. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

4. Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortium

5. Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular biology, genetic, and epigenetics of prostate tumor;Genetics and Epigenetics of Genitourinary Diseases;2025

2. Effect of genetic profiling on surgical decisions at hereditary colorectal cancer syndromes;Heliyon;2024-08

3. Innovative Drug Modalities for the Treatment of Advanced Prostate Cancer;Diseases;2024-05-02

4. Rucaparib monotherapy in the heavily pre-treated metastatic castrate-resistant prostate cancer setting: practical considerations and alternate treatment approaches;Translational Andrology and Urology;2024-05

5. Genetic Signatures for Distinguishing Chemo-Sensitive from Chemo-Resistant Responders in Prostate Cancer Patients;Current Issues in Molecular Biology;2024-03-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3